On June 24, Skadden held a webinar titled “Merger Enforcement Issues in the Life Sciences Sector.” Skadden attorneys discussed the U.S. Federal Trade Commission’s recent actions in life sciences deals, which have demonstrated the agency’s commitment to vigorous enforcement against such deals involving traditional theories of harm and also exposed a sharp debate among the commissioners about how far to push the boundaries of antitrust enforcement to address rising health care costs and perceived high prices. Global antitrust/competition head Steven Sunshine and partners Maria Raptis and David Wales spoke.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates